ViewRay Insiders

VRAYDelisted Stock  USD 0.04  0  5.67%   
ViewRay employs about 295 people. The company is managed by 10 executives with a total tenure of roughly 16 years, averaging almost 1.0 years of service per executive, having 29.5 employees per reported executive. Break down of ViewRay's management performance can provide insight into the company performance.
James Dempsey  Director
Chief Scientific Officer, Director
  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

ViewRay Management Team Effectiveness

The company has return on total asset (ROA) of (0.2529) % which means that it has lost $0.2529 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.0891) %, meaning that it created substantial loss on money invested by shareholders. ViewRay's management efficiency ratios could be used to measure how well ViewRay manages its routine affairs as well as how well it operates its assets and liabilities.

ViewRay Workforce Comparison

ViewRay is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 12,515. ViewRay holds roughly 295 in number of employees claiming about 2.36% of equities under Health Care industry.
The company has Profit Margin (PM) of (1.04) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.02) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.02.

ViewRay Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific ViewRay insiders, such as employees or executives, is commonly permitted as long as it does not rely on ViewRay's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, ViewRay insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

ViewRay Notable Stakeholders

A ViewRay stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as ViewRay often face trade-offs trying to please all of them. ViewRay's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting ViewRay's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
James DempseyChief Scientific Officer, DirectorProfile
Robert McCormackChief OfficerProfile
Robert FuchsChief OfficerProfile
Zachary StassenChief OfficerProfile
Martin MDChief OfficerProfile
JD ZieglerChief OfficerProfile
Karen HackstaffVP MarketingProfile
Scott DrakeCEO PresProfile
Matt HarrisonDirector RelationsProfile
Drew HillVP DevelProfile

About ViewRay Management Performance

The success or failure of an entity such as ViewRay often depends on how effective the management is. ViewRay management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of ViewRay management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the ViewRay management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company was founded in 2004 and is headquartered in Oakwood, Ohio. Viewray operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 267 people.
Please note, the imprecision that can be found in ViewRay's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of ViewRay. Check ViewRay's Beneish M Score to see the likelihood of ViewRay's management manipulating its earnings.

ViewRay Workforce Analysis

Traditionally, organizations such as ViewRay use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare ViewRay within its industry.

ViewRay Manpower Efficiency

Return on ViewRay Manpower

Revenue Per Employee346.5K
Revenue Per Executive10.2M
Net Loss Per Employee363.8K
Net Loss Per Executive10.7M
Working Capital Per Employee446.7K
Working Capital Per Executive13.2M
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Other Consideration for investing in ViewRay Stock

If you are still planning to invest in ViewRay check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ViewRay's history and understand the potential risks before investing.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Equity Valuation
Check real value of public entities based on technical and fundamental data
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences